JRCT ID: jRCT2080220732
Registered date:13/05/2009
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Pain |
Date of first enrollment | 13/05/2009 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : AZD1386 INN of investigational material : Therapeutic category code : 114 Antipyretics, analgesics and anti-inflammatory agents Dosage and Administration for Investigational material : Oral, during 4 weeks |
Outcome(s)
Primary Outcome | |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 40age old |
---|---|
Age maximum | <= 80age old |
Gender | Both |
Include criteria | - Patients with OA of the knee |
Exclude criteria | - A current diagnosis of another form of arthritis, in addition to OA - History, and/or presence of somatic disease, which may interfere with the objectives |
Related Information
Primary Sponsor | AstraZeneca |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-090760 |
Contact
Public contact | |
Name | |
Address | RD-clinical-information-Japan@astrazeneca.com |
Telephone | |
Affiliation | AstraZeneca KK |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |